$RARE Income Statement | Understand Stock

$RARE

$16.75 +$0.67 (4.17%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product sales
Royalty
Collaboration and license
Total revenues
Operating expenses:
Cost of sales
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Interest income
Change in fair value of equity investments
Non-cash interest expense on liabilities for sales of future royalties
Other income (expense)
Loss before income taxes
(Provision for) benefit from income taxes
Net loss
Net loss per share, basic and diluted
Weighted-average shares used in computing net loss per share, basic and diluted
Net loss per share, basic
Net loss per share, diluted
Shares used in computing net loss per share, Basic
Shares used in computing net loss per share, Diluted

Comments